(Q33756726)

29 July 2017

1 reference

title

Gabapentin in the management of convulsive disorders (English)

1 reference

29 July 2017

0 references

M J McLean

1

1 reference

29 July 2017

1 January 1999

1 reference

29 July 2017

1 reference

29 July 2017

40 Suppl 6

1 reference

29 July 2017

S39-50; discussion S73-4

1 reference

A summary of mechanistic hypotheses of gabapentin pharmacology

29 July 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1999.TB00932.X

Characterisation of [3H]gabapentin binding to a novel site in rat brain: homogenate binding studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1999.TB00932.X

Localization of [3H]gabapentin to a novel site in rat brain: autoradiographic studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1999.TB00932.X

The novel anticonvulsant drug, gabapentin (Neurontin), binds to the alpha2delta subunit of a calcium channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1999.TB00932.X

The effect of gabapentin on brain gamma-aminobutyric acid in patients with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1999.TB00932.X

Effects of anticonvulsant drug gabapentin on the enzymes in metabolic pathways of glutamate and GABA

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1999.TB00932.X

Gabapentin increases aminooxyacetic acid-induced GABA accumulation in several regions of rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1999.TB00932.X

Neurochemical actions of gabapentin in mouse brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1999.TB00932.X

Vigabatrin enhances promoted release of GABA in neonatal rat optic nerve.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1999.TB00932.X

Topiramate increases brain GABA, homocarnosine, and pyrrolidinone in patients with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1999.TB00932.X

Vigabatrin increases human brain homocarnosine and improves seizure control

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1999.TB00932.X

Limitation by gabapentin of high frequency action potential firing by mouse central neurons in cell culture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1999.TB00932.X

Gabapentin inhibits calcium currents in isolated rat brain neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1999.TB00932.X

Serotonin facilitates GABAergic transmission in the CA1 region of rat hippocampus in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1999.TB00932.X

Inhibition by GABA, baclofen and gabapentin of dopamine release from rabbit caudate nucleus: are there common or different sites of action?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1999.TB00932.X

Effect of a high-protein meal on gabapentin pharmacokinetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1999.TB00932.X

Gabapentin absorption: effect of mixing with foods of varying macronutrient composition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1999.TB00932.X

Selected CSF biochemistry and gabapentin concentrations in the CSF and plasma in patients with partial seizures after a single oral dose of gabapentin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1999.TB00932.X

Lack of a pharmacokinetic interaction between phenobarbitone and gabapentin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1999.TB00932.X

Cataplexy and monoamine oxidase deficiency in Norrie disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1999.TB00932.X

Changes in body weight with chronic, high-dose gabapentin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1999.TB00932.X

Gabapentin for behavioral agitation in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1999.TB00932.X

Pancreatic acinar cell neoplasia in male Wistar rats following 2 years of gabapentin exposure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1999.TB00932.X

10.1111/J.1528-1157.1999.TB00932.X

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10530682